Efficacy of hypnotherapy compared to cognitive-behavioural therapy for mild-to-moderate depression: study protocol of a randomised-controlled rater-blind trial (WIKI-D)

被引:10
|
作者
Fuhr, Kristina [1 ]
Schweizer, Cornelie [1 ]
Meisner, Christoph [2 ]
Batra, Anil [1 ]
机构
[1] Univ Hosp Tuebingen, Dept Psychiat & Psychotherapy, Tubingen, Germany
[2] Univ Tubingen, Inst Clin Epidemiol & Appl Biometry, Tubingen, Germany
来源
BMJ OPEN | 2017年 / 7卷 / 11期
关键词
WORKING ALLIANCE; PSYCHOTHERAPY; PREVENTION;
D O I
10.1136/bmjopen-2017-016978
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Despite a substantial number of studies providing evidence for the efficacy of psychological treatment for mild-to-moderate depression, maximally only 50% of participants respond to treatment, even when using gold-standard treatments such as cognitive-behavioural therapy (CBT) and interpersonal therapy. New approaches such as the 'third wave' psychotherapies have provided promising results; however, studies concerning the comparison with evidence-based treatments are lacking. This study aims to compare the efficacy of clinical hypnotherapy (HT) with gold-standard psychotherapy (CBT) in the treatment of mild-to-moderate major depressive episodes. Methods and analysis The present study comprises a monocentric, two-armed, randomised-controlled, rater-blind (non-inferiority) clinical trial. A total of 160 participants with mild-to-moderate major depression episode will be randomly assigned to either CBT or HT involving 20 sessions of psychotherapy over a period of 24 weeks. We predict that the average improvement in the Montgomery-Asberg Depression Rating Scale score will not be inferior in HT compared with CBT (non-inferiority hypothesis). Further outcome parameters will include the number of participants responding to treatment following the completion of treatment and 1 year after. Additionally, quality of life, treatment expectations and hypnotic susceptibility before and after end of treatment will be assessed. Ethics and dissemination The study protocol and the documents for the informed consent have been approved by the Ethics Committee of the University Hospital Tuebingen (061/ 2015B02). The results of this trial will be submitted for publication in peer-reviewed journals, and will be presented at national and international conferences.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Efficacy of hypnotherapy compared to cognitive behavioral therapy for mild to moderate depression-Results of a randomized controlled rater-blind clinical trial
    Fuhr, Kristina
    Meisner, Christoph
    Broch, Angela
    Cyrny, Barbara
    Hinkel, Juliane
    Jaberg, Joana
    Petrasch, Monika
    Schweizer, Cornelie
    Stiegler, Anette
    Zeep, Christina
    Batra, Anil
    JOURNAL OF AFFECTIVE DISORDERS, 2021, 286 : 166 - 173
  • [2] Efficacy of hypnotherapy compared to cognitive behavioral therapy for mild to moderate depression - Results of a randomized controlled rater-blind clinical trial (vol 286, pg 166, 2021)
    Fuhr, Kristina
    Meisner, Christoph
    Broch, Angela
    Cyrny, Barbara
    Hinkel, Juliane
    Jaberg, Joana
    Petrasch, Monika
    Schweizer, Cornelie
    Stiegler, Anette
    Zeep, Christina
    Batra, Anil
    JOURNAL OF AFFECTIVE DISORDERS, 2021, 289 : 180 - 180
  • [3] Cognitive-behavioural group therapy for adolescents with ADHD: study protocol for a randomised controlled trial
    Novik, Torunn Stene
    Haugan, Anne-Lise Juul
    Lydersen, Stian
    Thomsen, Per Hove
    Young, Susan
    Sund, Anne Mari
    BMJ OPEN, 2020, 10 (03): : e032839
  • [4] Clinical efficacy of computerised cognitive-behavioural therapy for anxiety and depression in primary care: randomised controlled trial
    Proudfoot, J
    Ryden, C
    Everitt, B
    Shapiro, DA
    Goldberg, D
    Mann, A
    Tylee, A
    Marks, I
    Gray, JA
    BRITISH JOURNAL OF PSYCHIATRY, 2004, 185 : 46 - 54
  • [5] Study protocol for a randomised controlled trial of a cognitive-behavioural prevention programme for the children of parents with depression: the PRODO trial
    Platt, Belinda
    Pietsch, Kathrin
    Krick, Kathrin
    Oort, Frans
    Schulte-Koerne, Gerd
    BMC PSYCHIATRY, 2014, 14
  • [6] Study protocol for a randomised controlled trial of a cognitive-behavioural prevention programme for the children of parents with depression: the PRODO trial
    Belinda Platt
    Kathrin Pietsch
    Kathrin Krick
    Frans Oort
    Gerd Schulte-Körne
    BMC Psychiatry, 14
  • [7] Digital cognitive-behavioural therapy application compared with zolpidem for the treatment of insomnia: protocol for an exploratory randomised controlled trial
    Shimizu, Eiji
    Sato, Daisuke
    Hirano, Yoshiyuki
    Ebisu, Haruna
    Kagayama, Yuki
    Hanaoka, Hideki
    BMJ OPEN, 2024, 14 (06):
  • [8] Virtual reality cognitive-behavioural therapy versus cognitive-behavioural therapy for paranoid delusions: a study protocol for a single-blind multi-Centre randomised controlled superiority trial
    M. Berkhof
    E. C. D. van der Stouwe
    B. Lestestuiver
    E. van’t Hag
    R. van Grunsven
    J. de Jager
    E. Kooijmans
    C. E. R. Zandee
    A. B. P. Staring
    R. M. C. A. Pot-Kolder
    M. Vos
    W. Veling
    BMC Psychiatry, 21
  • [9] Virtual reality cognitive-behavioural therapy versus cognitive-behavioural therapy for paranoid delusions: a study protocol for a single-blind multi-Centre randomised controlled superiority trial
    Berkhof, M.
    van der Stouwe, E. C. D.
    Lestestuiver, B.
    Van't Hag, E.
    van Grunsven, R.
    de Jager, J.
    Kooijmans, E.
    Zandee, C. E. R.
    Staring, A. B. P.
    Pot-Kolder, R. M. C. A.
    Vos, M.
    Veling, W.
    BMC PSYCHIATRY, 2021, 21 (01)
  • [10] Efficacy and safety of BSZY cream for mild-to-moderate atopic facial dermatitis: protocol of a randomised, double-blind, controlled trial
    Wang, Peiyao
    Wei, Xuqiang
    Cheng, Linyan
    Guo, Dongjie
    Du, Ting
    Guo, Wanjun
    Xi, Ruofan
    Duan, Yanjuan
    Liu, Xin
    Wang, Yi
    Lu, Hanzhi
    Yan, Ge
    Zhu, Jianyong
    Hua, Liang
    Li, Fulun
    BMJ OPEN, 2025, 15 (03):